Category WHO

WHO Executive Board Wraps Up Post-WHA Work

At the World Health Organization 135th Executive Board meeting this week, member states discussed improvements to cut down on lengthy World Health Assemblies, and adopted two reports for further discussion on surgical care and anaesthesia, and the health impact of air pollution.

NCDs As Global Policy Concern: WHO Approves Plan To Tackle Scourge

The prevention and control of non-communicable diseases (NCDs) stands high on the agenda of World Health Organization member countries, many of them said last week. Governments called for a multi-stakeholder approach to tackle the problem, governed by firm rules, and some asked for ways to regulate products that increase risk factors.

World Health Assembly Approves Plan To Strengthen Access To Essential Medicines

World Health Organization members tonight approved a resolution aimed at improving access to essential medicines. Agreement came after a compromise on a proposed provision referencing other medicines that are not qualified as essential medicines.

WHO Agrees Plan For Sustainable R&D For Developing Countries; TDR May Host Pooled Fund

World Health Organization members in committee today agreed on a plan taking forward efforts to find alternative financing for diseases predominantly afflicting poor populations. The draft decision was modified overnight to address concerns that the agreed path assess projects on…

WHO Wrestles With Plan To Pursue R&D For Neglected Diseases

World Health Organization members today are expected to address a proposal on future efforts to find a solution to the longstanding problem of sustainable funding for research into diseases predominantly afflicting poor populations. An effort to close the topic yesterday was delayed when a proposal was put forward that named a WHO department as the potential host of the future activities on this issue.

WHA: Experts Discuss Innovation, Access For Middle Income Countries

Country officials, academics and leading global health advocates this week raised one of the key concerns of this year’s World Health Assembly: innovation and access to medicines in middle-income countries. Government procurement strategies, voluntary and compulsory licensing, de-linkage models and UNITAID mechanisms were among some of the solutions put forward.